| Before | After | p value |
Number of patients | n = 86 | n = 33 |
|
Age | 60 ± 13 |
|
|
Male/female | 23/63 |
|
|
Duration of Synofit® administration (weeks) |
| 4.6 ± 2.4 |
|
Pain, VAS (0 - 10) | 6.6 ± 1.7 | 4.9 ± 2.7 | 0.0001 |
Physical condition, VAS (0 - 10) | 6.2 ± 1.8 | 4.6 ± 2.7 | 0.0001 |
Joint stiffness, VAS (0 - 10) | 5.6 ± 2.6 | 4.3 ± 3.1 | 0.0157 |
Evaluation of the benefit (−1 to +3) |
| 1.0 ± 0.24 |
|
Effect on the quality of life (−1 to +3) |
| 0.85 ± 1.12 |
|